Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Mol Cell Cardiol. 2014 Nov 29;79:224–231. doi: 10.1016/j.yjmcc.2014.11.021

Figure 4.

Figure 4

EMAP II AB increased angiogenesis after chronic MI. (A) EMAP II AB increased progenitor ECs as shown by increased numbers of vWF+ and CD34+ endothelial cells. Left panels: vWF and CD34+ staining images; right panel: quantitative data. (B) EMAP II AB increased proliferating ECs as shown by representative photographs of Ki67+ endothelial cells (left panel) and quantification (right panel). (C) EMAP II AB increased capillary density. (D) EMAP II AB also increased blood vessel smooth muscle cells after chronic MI. *: p<0.05 compared with vehicle. n=5 for each group.